Stavudine and Dyslipidaemia - a phase IV clinical study of FDA data

Summary:

Dyslipidaemia is reported as a side effect among people who take Stavudine (stavudine), especially for people who are male, 30-39 old, have been taking the drug for 2 - 5 years also take Lamivudine, and have Hiv infection.

The phase IV clinical study analyzes which people have Dyslipidaemia when taking Stavudine. It is created by eHealthMe based on reports of 10,313 people who have side effects when taking Stavudine from the FDA, and is updated regularly.

What is Stavudine?

Stavudine has active ingredients of stavudine. eHealthMe is studying from 10,319 Stavudine users. Check the latest studies of Stavudine.

What is Dyslipidaemia?

Dyslipidaemia (abnormal amount of lipids) is found to be associated with 836 drugs and 711 conditions by eHealthMe. Check the latest studies of Dyslipidaemia.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 31, 2026

10,313 people reported to have side effects when taking Stavudine.
Among them, 71 people (0.69%) have Dyslipidaemia.

Could Stavudine cause Dyslipidaemia?

Among these 71 people:

How long have people been on Stavudine when they have Dyslipidaemia? *

  • < 1 month: 27.27 %
  • 1 - 6 months: 9.09 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 9.09 %
  • 2 - 5 years: 50.0 %
  • 5 - 10 years: 4.55 %
  • 10+ years: 0.0 %

What is the gender of people who have Dyslipidaemia when taking Stavudine? *

  • female: 34.43 %
  • male: 65.57 %

What is the age of people who have Dyslipidaemia when taking Stavudine? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 11.54 %
  • 20-29: 3.85 %
  • 30-39: 48.08 %
  • 40-49: 15.38 %
  • 50-59: 15.38 %
  • 60+: 5.77 %

What are other drugs people take besides Stavudine? *

  1. Lamivudine: 25 people, 35.21%
  2. Zidovudine: 23 people, 32.39%
  3. Didanosine: 21 people, 29.58%
  4. Efavirenz: 20 people, 28.17%
  5. Nevirapine: 14 people, 19.72%
  6. Abacavir: 13 people, 18.31%
  7. Tenofovir Disoproxil Fumarate: 13 people, 18.31%
  8. Emtricitabine: 10 people, 14.08%
  9. Ritonavir: 10 people, 14.08%
  10. Lopinavir And Ritonavir: 8 people, 11.27%

What are other side effects people have besides Dyslipidaemia? *

  1. Lipodystrophy Acquired (a regional loss of subcutaneous adipose tissue which usually starts in the face, extends downward acquired): 55 people, 77.46%
  2. Fat Tissue Increased: 18 people, 25.35%
  3. Renal Impairment (severely reduced kidney function): 17 people, 23.94%
  4. Musculoskeletal Pain (pain affects the bones, muscles, ligaments, tendons, and nerves): 16 people, 22.54%
  5. Bone Metabolism Disorder: 16 people, 22.54%
  6. Pathological Fracture (broken bone caused by disease): 16 people, 22.54%
  7. Chronic Kidney Disease: 16 people, 22.54%
  8. Hypophosphataemia (electrolyte disturbance in which there is an abnormally low level of phosphate in the blood): 16 people, 22.54%
  9. Mobility Decreased (ability to move is reduced): 14 people, 19.72%
  10. Overdose: 14 people, 19.72%

What are the existing conditions these people have? *

  1. Hiv Infection: 56 people, 78.87%
  2. Tuberculosis (a bacterial infection by mycobacterium tuberculosis): 2 people, 2.82%
  3. Pneumocystis Jiroveci Infection (fungal infection of the lungs): 2 people, 2.82%
  4. Lipids Increased (excess lipid in body): 2 people, 2.82%
  5. Intracranial Pressure Increased (high pressure inside the skull and thus in the brain tissue and cerebrospinal fluid): 2 people, 2.82%
  6. High Blood Cholesterol: 2 people, 2.82%
  7. Acquired Immunodeficiency Syndrome (disease of the human immune system caused by the human immunodeficiency virus (hiv)): 2 people, 2.82%
  8. Viral Load Increased: 1 person, 1.41%
  9. Lung Infection: 1 person, 1.41%
  10. Hiv Test Positive: 1 person, 1.41%

* Approximation only. Some reports may have incomplete information.

Do you take Stavudine and have Dyslipidaemia?

- Check whether Dyslipidaemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Stavudine:

Dyslipidaemia treatments and more:

How severe was Dyslipidaemia and when was it recovered:

Expand to all the drugs that have ingredients of stavudine:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Stavudine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dyslipidaemia:

Browse all the conditions that are associated with Dyslipidaemia:


How the study uses the data?

The study uses data from the FDA. It is based on stavudine (the active ingredients of Stavudine) and Stavudine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: